S&P 500   3,211.61 (-0.46%)
DOW   26,715.40 (-0.58%)
QQQ   258.60 (-0.88%)
AAPL   386.04 (-1.24%)
MSFT   204.08 (-1.90%)
FB   240.03 (-0.10%)
GOOGL   1,507.14 (-0.64%)
AMZN   3,016.53 (+0.25%)
NVDA   405.65 (-0.84%)
CGC   17.90 (-1.38%)
BABA   244.41 (-1.93%)
MU   50.09 (-0.83%)
GE   7.11 (-0.42%)
TSLA   1,525.25 (-1.34%)
AMD   54.54 (-1.45%)
T   30.30 (+0.97%)
ACB   12.06 (-6.29%)
F   6.84 (+1.48%)
GILD   76.16 (-0.64%)
DIS   119.38 (-1.28%)
NFLX   527.15 (+0.74%)
BAC   23.90 (-2.85%)
BA   181.23 (-3.57%)
S&P 500   3,211.61 (-0.46%)
DOW   26,715.40 (-0.58%)
QQQ   258.60 (-0.88%)
AAPL   386.04 (-1.24%)
MSFT   204.08 (-1.90%)
FB   240.03 (-0.10%)
GOOGL   1,507.14 (-0.64%)
AMZN   3,016.53 (+0.25%)
NVDA   405.65 (-0.84%)
CGC   17.90 (-1.38%)
BABA   244.41 (-1.93%)
MU   50.09 (-0.83%)
GE   7.11 (-0.42%)
TSLA   1,525.25 (-1.34%)
AMD   54.54 (-1.45%)
T   30.30 (+0.97%)
ACB   12.06 (-6.29%)
F   6.84 (+1.48%)
GILD   76.16 (-0.64%)
DIS   119.38 (-1.28%)
NFLX   527.15 (+0.74%)
BAC   23.90 (-2.85%)
BA   181.23 (-3.57%)
S&P 500   3,211.61 (-0.46%)
DOW   26,715.40 (-0.58%)
QQQ   258.60 (-0.88%)
AAPL   386.04 (-1.24%)
MSFT   204.08 (-1.90%)
FB   240.03 (-0.10%)
GOOGL   1,507.14 (-0.64%)
AMZN   3,016.53 (+0.25%)
NVDA   405.65 (-0.84%)
CGC   17.90 (-1.38%)
BABA   244.41 (-1.93%)
MU   50.09 (-0.83%)
GE   7.11 (-0.42%)
TSLA   1,525.25 (-1.34%)
AMD   54.54 (-1.45%)
T   30.30 (+0.97%)
ACB   12.06 (-6.29%)
F   6.84 (+1.48%)
GILD   76.16 (-0.64%)
DIS   119.38 (-1.28%)
NFLX   527.15 (+0.74%)
BAC   23.90 (-2.85%)
BA   181.23 (-3.57%)
S&P 500   3,211.61 (-0.46%)
DOW   26,715.40 (-0.58%)
QQQ   258.60 (-0.88%)
AAPL   386.04 (-1.24%)
MSFT   204.08 (-1.90%)
FB   240.03 (-0.10%)
GOOGL   1,507.14 (-0.64%)
AMZN   3,016.53 (+0.25%)
NVDA   405.65 (-0.84%)
CGC   17.90 (-1.38%)
BABA   244.41 (-1.93%)
MU   50.09 (-0.83%)
GE   7.11 (-0.42%)
TSLA   1,525.25 (-1.34%)
AMD   54.54 (-1.45%)
T   30.30 (+0.97%)
ACB   12.06 (-6.29%)
F   6.84 (+1.48%)
GILD   76.16 (-0.64%)
DIS   119.38 (-1.28%)
NFLX   527.15 (+0.74%)
BAC   23.90 (-2.85%)
BA   181.23 (-3.57%)
Log in

NASDAQ:CLGNCOLLPLANT HOLDI/S Stock Price, Forecast & News

$9.20
-0.20 (-2.13 %)
(As of 07/16/2020 01:32 PM ET)
Add
Compare
Today's Range
$9.20
Now: $9.20
$9.20
50-Day Range
$9.01
MA: $9.94
$10.38
52-Week Range
$3.35
Now: $9.20
$14.55
Volume100 shs
Average Volume4,785 shs
Market Capitalization$52.16 million
P/E RatioN/A
Dividend YieldN/A
Beta1.08
CollPlant Holdings Ltd., a regenerative medicine company, focuses on developing and commercializing tissue repair products for three-dimensional (3D) bio-printing of tissues and organs, dermal fillers for aesthetics, orthobiologics, and advanced wound care markets in the United States, Canada, and Europe. The company's products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. Its products include VergenixSTR, a soft tissue repair matrix intended for treatment of tendinopathy; VergenixFG, a wound-filling flowable gel for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; and BioInks for 3D printing of tissues and organs. CollPlant Holdings Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.14 out of 5 stars


Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:CLGN
CUSIPN/A
CIKN/A
Phone972-73-232-5600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.32 million
Book Value$0.72 per share

Profitability

Net Income$-11,160,000.00
Net Margins-404.33%

Miscellaneous

Employees40
Market Cap$52.16 million
Next Earnings Date9/24/2020 (Estimated)
OptionableNot Optionable

Receive CLGN News and Ratings via Email

Sign-up to receive the latest news and ratings for CLGN and its competitors with MarketBeat's FREE daily newsletter.

COLLPLANT HOLDI/S (NASDAQ:CLGN) Frequently Asked Questions

How has COLLPLANT HOLDI/S's stock been impacted by COVID-19 (Coronavirus)?

COLLPLANT HOLDI/S's stock was trading at $10.20 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CLGN stock has decreased by 9.8% and is now trading at $9.20. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of COLLPLANT HOLDI/S?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for COLLPLANT HOLDI/S in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for COLLPLANT HOLDI/S.

When is COLLPLANT HOLDI/S's next earnings date?

COLLPLANT HOLDI/S is scheduled to release its next quarterly earnings announcement on Thursday, September 24th 2020. View our earnings forecast for COLLPLANT HOLDI/S.

How were COLLPLANT HOLDI/S's earnings last quarter?

COLLPLANT HOLDI/S (NASDAQ:CLGN) released its quarterly earnings results on Wednesday, May, 27th. The company reported ($0.26) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.50) by $0.24. The business earned $0.61 million during the quarter, compared to analyst estimates of $0.70 million. COLLPLANT HOLDI/S had a negative net margin of 404.33% and a negative return on equity of 334.65%. View COLLPLANT HOLDI/S's earnings history.

What price target have analysts set for CLGN?

1 brokerages have issued 12-month price targets for COLLPLANT HOLDI/S's shares. Their forecasts range from $13.00 to $13.00. On average, they anticipate COLLPLANT HOLDI/S's stock price to reach $13.00 in the next twelve months. This suggests a possible upside of 41.3% from the stock's current price. View analysts' price targets for COLLPLANT HOLDI/S.

Has COLLPLANT HOLDI/S been receiving favorable news coverage?

News articles about CLGN stock have trended somewhat negative recently, according to InfoTrie. The research firm identifies negative and positive press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. COLLPLANT HOLDI/S earned a coverage optimism score of -1.9 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future. View the latest news about COLLPLANT HOLDI/S.

Who are some of COLLPLANT HOLDI/S's key competitors?

What other stocks do shareholders of COLLPLANT HOLDI/S own?

Who are COLLPLANT HOLDI/S's key executives?

COLLPLANT HOLDI/S's management team includes the following people:
  • Prof. Oded Shoseyov, Founder & Chief Scientist Officer (Age 63)
  • Mr. Eran Rotem, Deputy CEO & CFO (Age 51)
  • Dr. Philippe David Bensimon, VP of Regulation Affairs & Quality Assurance (Age 54)
  • Dr. Nadav Orr, VP of R&D (Age 62)
  • Mr. Yehiel Tal, Chief Exec. Officer (Age 67)

When did COLLPLANT HOLDI/S IPO?

(CLGN) raised $22 million in an initial public offering on Friday, December 9th 2016. The company issued 3,500,000 shares at a price of $6.23 per share. Ladenburg Thalmann acted as the underwriter for the IPO and Roth Capital Partners was co-manager.

What is COLLPLANT HOLDI/S's stock symbol?

COLLPLANT HOLDI/S trades on the NASDAQ under the ticker symbol "CLGN."

How do I buy shares of COLLPLANT HOLDI/S?

Shares of CLGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is COLLPLANT HOLDI/S's stock price today?

One share of CLGN stock can currently be purchased for approximately $9.20.

How big of a company is COLLPLANT HOLDI/S?

COLLPLANT HOLDI/S has a market capitalization of $52.16 million and generates $2.32 million in revenue each year. The company earns $-11,160,000.00 in net income (profit) each year or ($1.29) on an earnings per share basis. COLLPLANT HOLDI/S employs 40 workers across the globe.

What is COLLPLANT HOLDI/S's official website?

The official website for COLLPLANT HOLDI/S is www.collplant.com.

How can I contact COLLPLANT HOLDI/S?

COLLPLANT HOLDI/S's mailing address is 4 OPPENHEIMER ST. 11TH FLOOR, REHOVOT L3, 74140. The company can be reached via phone at 972-73-232-5600 or via email at [email protected]

This page was last updated on 7/16/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.